| LURASIDONE/PHARMAZAC F.C.TAB 37MG/TAB BT x 28 |
| LURASIDONE/PHARMAZAC F.C.TAB 74MG/TAB BT x 28 |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | Pharmazac S.A. |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
| LURASIDONE/PHARMAZAC F.C.TAB 37MG/TAB BT x 28 |
| LURASIDONE/PHARMAZAC F.C.TAB 74MG/TAB BT x 28 |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | Pharmazac S.A. |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |